Project Details
| Status | Active |
|---|---|
| Effective start/end date | 27/05/24 → 26/05/29 |
Clinical Trial Phase
- Phase III (a & b)
A Phase 3, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate The Efficacy And Safety of Ravulizumab in Adult Participants with Immunoglobulin A Nephropathy (IgAN)
- Ryan, Jessica (Primary Chief Investigator (PCI))
Project: Research